Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes
Author:
Affiliation:
1. Coromed Kft., Private Cardiology Practice, Pécs, Hungary
2. Heart Institute, University of Pécs, General Faculty of Medicine, Pécs, Hungary
3. Institute of Biophysics, University of Pécs, General Faculty of Medicine, Pécs, Hungary
Abstract
Publisher
Future Medicine Ltd
Subject
Health Policy
Link
https://www.futuremedicine.com/doi/pdf/10.2217/cer-2017-0011
Reference35 articles.
1. WHO library cataloguing-in-publication data, World health statistics. ISBN 978 92 4 156526 4, (2016). www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf.
2. 2013 ESC guidelines on the management of stable coronary artery disease
3. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
4. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double‐blind placebo‐controlled trial (EMPT‐ANGINA Trial);Clinical Cardiology;2023-09-18
2. Fulminant myocarditis-associated expanded dengue syndrome in pregnant woman: a case report;Bulletin of the National Research Centre;2022-10-26
3. Effect of trimetazidine in experimental animals with coronary heart disease or and in combination with diabetes mellitus;International Journal of Clinical Biochemistry and Research;2022-03-15
4. Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway;Frontiers in Pharmacology;2022-03-03
5. Actualización del uso de los fármacos antianginosos en el tratamiento del síndrome coronario crónico: enfoque práctico;Revista Española de Cardiología Suplementos;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3